 |
 |
 |
|
No Evidence of Residual Virus Replication in a Randomised
Controlled Trial of Dolutegravir Intensification
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Thomas A Rasmussen*, James McMahon*, Judy Chang, Jennifer Audsley, Ajantha Rhodes, Surekha Tennakoon, Ashanti Dantanarayana, Tim Spelman, Tina Schmidt, Stephen Kent, Vincent Morcilla, Sarah Palmer, Julian H Elliott, Sharon R Lewin
webcast: http://www.croiwebcasts.org/console/player/37167?mediaType=slideVideo&&crd_fl=1&ssmsrq=1520444191011&ctms=5000&csmsrq=803







|
|
|
 |
 |
|
|